Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence

ChIP-seq for AR, FOXA1 and H3K27ac in primary prostate tumors before and after 3 months of neoadjuvant enzalutamide treatment.RNA-seq expression data of primary prostate tumors before and after 3 months of neoadjuvant enzalutamide treatment.针对AR、FOXA1和H3K27ac在初诊前列腺肿瘤中的ChIP-seq数据，以及在接受3个月新辅助恩杂鲁胺治疗后3个月内的数据。新辅助恩杂鲁胺治疗后3个月内的前列腺肿瘤RNA测序表达数据。